XML 60 R46.htm IDEA: XBRL DOCUMENT v3.6.0.2
STOCK-BASED COMPENSATION - Performance Contingent RSAs and RSUs (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Jan. 14, 2016
shares
Jun. 02, 2014
May 31, 2014
USD ($)
Dec. 31, 2016
USD ($)
shares
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Dec. 31, 2011
shares
Stock-based compensation              
Stock-based compensation expense       $ 8,297 $ 6,873 $ 27,390  
TSR and Performance Measures | Senior Management              
Stock-based compensation              
Stock-based compensation expense       $ 2,000      
Minimum payout of shares (in shares) | shares       0      
Maximum payout of shares (in shares) | shares       328,688      
Timeframe for calculation of TSR       2 years      
TSR and Performance Measures - to be Vested and Distributed February 20, 2018 | Senior Management              
Stock-based compensation              
Vesting percentage       67.00%      
TSR and Performance Measures - to be Vested and Distributed February 20, 2019 | Senior Management              
Stock-based compensation              
Vesting percentage       33.00%      
RSAs              
Stock-based compensation              
Stock-based compensation expense       $ 3,492 2,850 7,575  
RSAs | Performance-contingent              
Stock-based compensation              
Stock-based compensation expense       $ 1,293 613 10,580  
RSAs | Performance-contingent | Senior Management              
Stock-based compensation              
Shares of common stock approved and authorized for issuance | shares             1,290,000
Timeframe for achievement of performance conditions             6 years
Stock-based compensation expense     $ 7,000        
Outstanding (in shares) | shares       63,000      
RSAs | TSR and Performance Measures | Senior Management              
Stock-based compensation              
Granted (in shares) | shares 282,394            
RSUs              
Stock-based compensation              
Stock-based compensation expense       $ 1,920 2,492 4,564  
RSUs | Performance-contingent              
Stock-based compensation              
Stock-based compensation expense       0 $ 0 $ 3  
RSUs | TSR and Performance Measures | Senior Management              
Stock-based compensation              
Granted (in shares) | shares 46,294            
Theravance Biopharma Spinoff              
Stock-based compensation              
Number of shares of Theravance Biopharma issued for every share of Theravance   0.286          
Special Long-Term Retention and Incentive Cash Awards Program | RSAs | Performance-contingent              
Stock-based compensation              
Stock-based compensation expense       $ 1,300